Le Lézard
Classified in: Health

FDAnews Announces -- Drug Pricing and Reimbursement: Navigating the Changes, Anticipating the Future Webinar, August 6, 2019


FALLS CHURCH, Va., July 23, 2019 /PRNewswire-PRWeb/ -- "For too long it's been virtually impossible for Americans to know the real price and quality of healthcare services and the services they receive. With today's historic action, we are fundamentally changing the nature of the healthcare marketplace. This is bigger than anything we've done in this particular realm."

?HHS Secretary Alex Azar

The drug pricing and reimbursement landscape is changing dramatically. From President Trump's June 24, 2019 executive order requiring healthcare providers to tell patients their out-of-pocket costs prior to receiving services, the May 2019 final rule requiring drug pricing in television ads, recent DOJ enforcement actions, to CMS rules for Medicare Part D and drug pricing bills working through Congressional committees.

Understanding the current policies ? and proposed changes ? and how to apply them to product development and commercialization plans will greatly impact the success of an organizations products.

Nationally recognized FDA regulatory and life sciences attorney Bethany Hills-Grois, a partner with Morrison & Foerster, is here to help and explain:

Understand the new drug pricing/reimbursement changes, the issues one needs to watch and the practical applications within an organization.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:
Drug Pricing and Reimbursement
Navigating the Changes, Anticipating the Future
**An FDAnews Webinar**
Tuesday, August 6, 2019 ? 1:30-3:00 p.m. EDT
https://www.fdanews.com/drugpricingandreimbursement

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/drugpricingandreimbursement
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDAnews


These press releases may also interest you

at 16:14
eNeura, a pioneering leader in therapeutic solutions, proudly announces a monumental milestone in its journey towards revolutionizing migraine treatment. With unwavering commitment to innovation and patient well-being, eNeura has already reached...

at 16:10
bluebird bio, Inc. today announced that it received a notice (the "notice") on April 24, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December...

at 16:10
Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company's upcoming annual...

at 16:00
This program will support individuals in Putnam County with Opioid Use Disorder and co-occurring substance use and mental health conditions through peer support and harm reduction for the broader Putnam County community. A...

at 15:49
Life Time continues its growth in Texas with two new athletic country clubs opening in the coming months. Located in Irving, Life Time Las Colinas opens April 26. Later this summer, the nearby Life Time Westlake will debut. A waitlist is now open....

at 15:44
Grossman Law Offices, with its principal office in Dallas, TX, expresses concern and support for Eric Elliott and his family following a truck accident that occurred on February 20, 2024, just before 4:45 p.m. along U.S. Highway 67 in Johnson County,...



News published on and distributed by: